Preparations for use in solid phase immunoassays comprising monoclonal antibodies covalently embedded in their immobilized hybridoma cells
AssigneeI.D.L. International Diagnostic Laboratories Limited
InventorsLynn Wang, Michael Inbar
Life of this patent
Estimating the term…
Abstract
A reagent for use in solid phase immunoassay diagnostics comprises a matrix of non-active hybridoma cells embedded with its self-produced, covalently bound, actively presented monoclonal antibodies. The solid phase reagent according to the invention is prepared by incubating in vitro a culture medium containing active hybridoma cells capable of producing monoclonal antibodies, allowing the formation of antibodies to proceed, separating and washing said cells, resuspending the cells in a buffer solution, adding to the resulting suspension an inactivator substance capable of converting active hybridoma cells into the non-active state.
Claims13
A reagent for use in solid phase immunoassay diagnostics comprising a matrix of fixed hybridoma cells embedded with and covalently bound to its self-produced monoclonal antibodies, said bound monoclonal antibodies presenting sites available for binding to a specific antigen, and at least one auxiliary substance selected from the group consisting of labelling materials, dyes and color reagents for use in colorimetric tests.
A process for the preparation of a solid reagent for use in diagnostic immunoassay, comprising incubating in vitro a culture medium containing active hybridoma cells capable of producing monoclonal antibodies, allowing the formation of antibodies to proceed, separating and washing said cells free of serum, resuspending the cells in a buffer solution, adding a fixative to the resulting suspension, thus covelently binding to said hybridoma cells these self-produced monoclonal antibodies which were incapable of removal from said hybridoma cells by said washing and resuspending steps theretby to produce an immobilized fixed hybridoma cells/monoclonal antibodies complex, binding excessive free inactivator substance and isolating said immobilized fixed hybridoma cells/monoclonal antibodies complex.
A reagent for use in solid phase immunoassay diagnostics consisting essentially of a matrix of fixed hybridoma cells embedded with and covalently bound to its self-produced monoclonal antibodies, said bound monoclonal antibodies presenting sites available for binding to a specific antigen.
Dependencies are inferred from the claim text.